Mark Eisner, Director of Jade Biosciences JBIO, has filed 0 purchases and 12 sales on the open market. Over the past 12 months that comes to a net sale of $49.5K. The latest trade was on 06/25.

ME

ME

Mark Eisner

Director

Company

Jade Biosciences JBIO

First filing

23/02/23

Trades

27 trades

Buys / sales

0 / 12

12-month net buying

−$49.5K

Last trade

06/25

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Vir BiotechnologyVIR	Open-market sale10b5-1 plan	02/24–02/25	02/26	3,505 sh2 trades	$9.69avg.	$33,950.46	−2.2%
Vir BiotechnologyVIR	Open-market sale10b5-1 plan	02/23	02/24	2,089 sh	$7.45	$15,563.05	−1.3%
Vir BiotechnologyVIR	Open-market sale10b5-1 plan	25/07/15–25/07/17	25/07/17	10,382 sh2 trades	$5.47avg.	$56,789.54	−9.0%
Kyntra BioKYNB	Open-market sale	23/06/07	23/06/09	2,042 sh	$17.04	$34,795.68	−1.2%
Kyntra BioKYNB	Open-market sale	23/06/02	23/06/05	1,090 sh	$18.83	$20,524.7	−0.7%
Kyntra BioKYNB	Open-market sale	23/04/04	23/04/06	9,182 sh	$18.78	$172,437.96	−5.2%
Kyntra BioKYNB	Open-market sale	23/03/08–23/03/10	23/03/10	17,503 sh3 trades	$20.60avg.	$360,629.08	−9.1%
Kyntra BioKYNB	Open-market sale	23/03/02	23/03/06	1,187 sh	$21.87	$25,959.69	−0.7%